PROCESS 9TH EDITION LILLEY COLLINS
SNYDER TEST BANK EXAM STUDY GUIDE
2026 TESTED QUESTIONS WITH FULL
SOLUTION
⩥ Brand Name. Answer: Name given by the drug manufacturer.
⩥ Nonproprietary Name. Answer: Generic name provided by USAN
Council.
⩥ United States Pharmacopoeia. Answer: Contains standards for
nutritional supplements.
⩥ Drug Facts and Comparisons. Answer: Contains monographs for all
therapeutic class drugs.
⩥ AHFS Drug Information. Answer: Monographs for nearly all single-
entity drugs.
⩥ DailyMed. Answer: Comprehensive online resource for medicines.
,⩥ Drug Monographs. Answer: Detailed descriptions of drugs in a class.
⩥ Natural Medicines Comprehensive Database. Answer: Evidence-
based info on herbal medicines.
⩥ Drug Interaction Facts. Answer: Information on drug interactions.
⩥ USP Dictionary of USAN. Answer: Compilation of drug names and
pronunciations.
⩥ Martindale—The Complete Drug Reference. Answer: Comprehensive
drug reference for various medications.
⩥ Nutritional Supplements. Answer: Products intended to supplement
diet.
⩥ Clinical Judgment. Answer: Decision-making based on clinical data.
⩥ Patient Education. Answer: Information provided to patients about
medications.
⩥ Cost Indices. Answer: Comparative pricing information for drugs.
,⩥ Dosage Forms. Answer: Forms in which drugs are available.
⩥ Therapeutic Uses. Answer: Approved and unapproved uses of drugs.
⩥ Healthcare Providers. Answer: Professionals who prescribe and
administer medications.
⩥ Public Access. Answer: Availability of drug information to general
public.
⩥ Safety. Answer: Considerations for preventing harm in drug use.
⩥ Physiological Integrity. Answer: Maintaining bodily functions and
health.
⩥ Federal Food, Drug, and Cosmetic Act. Answer: Legislation
authorizing FDA drug safety evaluation.
⩥ Durham Humphrey Amendment. Answer: Defines prescription-only
drugs requiring medical supervision.
⩥ Controlled Substances Act. Answer: Regulates controlled substances
and their categorization.
, ⩥ Kefauver Harris Drug Amendment. Answer: Mandates drug efficacy
proof before marketing.
⩥ Meperidine (Demerol). Answer: A Schedule II drug with high abuse
potential.
⩥ Schedule I Drugs. Answer: High abuse potential, no medical use
recognized.
⩥ Schedule II Drugs. Answer: High abuse potential, severe dependence
risk.
⩥ Schedule III Drugs. Answer: Moderate abuse potential, dependence
risk exists.
⩥ Schedule IV Drugs. Answer: Low abuse potential, limited dependence
risk.
⩥ Fast Tracking. Answer: Expedited FDA process for urgent drug
approvals.
⩥ Investigational New Drug Application. Answer: Application for FDA
approval of new drugs.